Aggarwal Gaurav
Insider CIK 1551965 · OCRX Chief Business Officer · SRRA Director, 10% owner · HPTX Director · UNCY Director · GERN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| UNCY Unicycive Therapeutics, In | D To issuer deriv | 2025-08-25 | 2025-08-26 | 3,199 | $1000.00 | $3.20M | 0 | SEC↗ |
| UNCY Unicycive Therapeutics, In | C Conversion | 2025-08-25 | 2025-08-26 | 652,900 | — | $0 | 1,789,915 | SEC↗ |
| UNCY Unicycive Therapeutics, In | A Award deriv | 2025-07-28 | 2025-07-30 | 21,200 | — | $0 | 39,200 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2025-05-21 | 2025-05-22 | 180,000 | — | $0 | 180,000 | SEC↗ |
| UNCY Unicycive Therapeutics, In | D To issuer deriv | 2025-02-18 | 2025-02-19 | 686 | $1000.00 | $686.0K | 3,119 | SEC↗ |
| UNCY Unicycive Therapeutics, In | C Conversion | 2025-02-18 | 2025-02-19 | 1,400,000 | — | $0 | 11,370,152 | SEC↗ |
| UNCY Unicycive Therapeutics, In | D To issuer deriv | 2024-10-09 | 2024-10-10 | 2,695 | $1000.00 | $2.69M | 3,885 | SEC↗ |
| UNCY Unicycive Therapeutics, In | C Conversion | 2024-10-09 | 2024-10-10 | 5,500,000 | — | $0 | 9,970,152 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2024-05-09 | 2024-05-10 | 180,000 | — | $0 | 180,000 | SEC↗ |
| GERN GERON CORP | A Award | 2023-12-29 | 2024-01-03 | 1,970 | — | $0 | 1,970 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2023-11-26 | 2023-11-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| UNCY Unicycive Therapeutics, In | A Award deriv | 2023-09-05 | 2023-09-07 | 180,000 | — | $0 | 180,000 | SEC↗ |
| UNCY Unicycive Therapeutics, In | C Conversion deriv | 2023-07-11 | 2023-07-13 | 12,802,388 | — | $0 | 12,802,388 | SEC↗ |
| UNCY Unicycive Therapeutics, In | C Conversion deriv | 2023-07-11 | 2023-07-13 | 11,638,534 | — | $0 | 11,638,534 | SEC↗ |
| UNCY Unicycive Therapeutics, In | C Conversion deriv | 2023-07-11 | 2023-07-13 | 18,621,655 | — | $0 | 18,621,655 | SEC↗ |
| UNCY Unicycive Therapeutics, In | C Conversion deriv | 2023-07-11 | 2023-07-13 | 13,429,000 | — | $0 | 13,429,000 | SEC↗ |
| UNCY Unicycive Therapeutics, In | C Conversion deriv | 2023-07-11 | 2023-07-13 | 8,077 | $1000.00 | $8.08M | 0 | SEC↗ |
| UNCY Unicycive Therapeutics, In | C Conversion | 2023-07-11 | 2023-07-13 | 3,470,152 | — | $0 | 3,470,152 | SEC↗ |
| UNCY Unicycive Therapeutics, In | A Award deriv | 2023-03-08 | 2023-03-09 | 8,077 | $1000.00 | $8.08M | 8,077 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 1,500 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 1,455,384 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 6,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 6,874 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 2,735,853 | $55.00 | $150.47M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | P Buy | 2022-01-31 | 2022-01-31 | 800,000 | $27.00 | $21.60M | 2,735,853 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 1,455,384 | $13.20 | $19.21M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 480,277 | $13.20 | $6.34M | 1,935,853 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2021-06-08 | 2021-06-09 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2020-06-09 | 2020-06-10 | 6,874 | — | $0 | 6,874 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 19,213 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 1,455,576 | — | $0 | 1,455,576 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2019-11-29 | 2019-12-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2016-01-15 | 2016-01-19 | 10,000 | $2.15 | $21.5K | 20,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-01-06 | 2016-01-07 | 147,975 | — | $0 | 147,975 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-01-06 | 2016-01-07 | 49,325 | — | $0 | 49,325 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2015-06-18 | 2015-06-22 | 75,000 | — | $0 | 75,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2015-05-06 | 2015-05-06 | 7,500 | $3.62 | $27.1K | 10,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2014-06-11 | 2014-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2014-04-30 | 2014-05-02 | 175,000 | — | $0 | 175,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | P Buy | 2012-07-31 | 2012-08-02 | 5,000 | $10.00 | $50.0K | 5,000 | SEC↗ |